FibroBiologics, Inc.: FibroBiologics CEO Issues Letter to Shareholders

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...